Paul Statkevich

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Natural Killer Cells

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin, Paul Statkevich, Akintunde Bello, Amit Roy, Satyendra Suryawanshi
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin, Paul Statkevich, Akintunde Bello, Amit Roy, Satyendra Suryawanshi
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin, Paul Statkevich, Akintunde Bello, Amit Roy, Satyendra Suryawanshi
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin, Paul Statkevich, Akintunde Bello, Amit Roy, Satyendra Suryawanshi
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nikhil I Khushalani, Adi Diab, Paolo Antonio Ascierto, James M G Larkin, Shahneen Sandhu, Mario Sznol, Henry B Koon, Anthony Jarkowski, Paul Statkevich, Paul Statkevich, William J Geese, Georgina V Long
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design. Future oncology (London, England) 16 (28) (2020)